Skip to content

Effects of Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Stress Reduction (MBSR) on symptoms and emotional competencies in individuals with multiple sclerosis.

Dena Sadeghi-Bahmani, Leila Esmaeili, Faezeh Mokhtari, Laleh Sadeghi Bahmani, Mahshad Afsharzadeh, Vahid Shaygannejad, Omid Mirmosayyeb, Andrea N Goldstein-Piekarski, James J. Gross

Multiple sclerosis and related disorders November 2022 DOI: 10.1016/j.msard.2022.104029 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 76
Population Adults with multiple sclerosis (81.6% female; mean age 38.88 years; EDSS median 2, range 0-5)
Interventions Acceptance and Commitment Therapy (ACT) Mindfulness-Based Stress Reduction (MBSR)
Duration 8-week intervention; assessments at baseline, week 4 (insomnia and depression), and week 8
Topics Depression Meditation
Keywords Emotional competencies Fatigue Insomnia Multiple sclerosis Paresthesia
Key findings Both ACT and MBSR reduced symptoms and improved emotional competencies in people with multiple sclerosis more than a wait-list control, with medium effect sizes for insomnia, fatigue, and paresthesia and large effect sizes for depression and emotional competencies. At study end, ACT and MBSR did not differ from each other.

Abstract

Compared to the general population, individuals with multiple sclerosis (MS) report higher levels of insomnia, depression, fatigue, and paresthesia, and lower levels of emotional competencies (understanding emotions in self and others). Available treatments are limited, and novel approaches to reducing symptoms and enhancing emotional competencies in MS are needed. Two potentially beneficial treatments are Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Stress Reduction (MBSR). The aim of the present study was to investigate the impact of ACT and MBSR on symptoms and emotional competencies in patients with MS. A total of 76 individuals with MS (81.6% females; mean age: 38.88 years; EDSS median: 2; range: 0-5) were randomly assigned to an 8-week ACT treatment, an 8-week MBSR treatment, or a wait-list control condition. At baseline and study-end (week 8), participants completed a series of questionnaires covering symptoms and emotional competencies. At mid-term (week 4), participants rated their insomnia and depression. Over time, symptoms of MS decreased (medium effect size for insomnia, fatigue, and paresthesia, and large effect size for depression) and emotional competencies improved (large effect size), but more so in the MBSR and ACT conditions, compared with the control condition. At study-end, the outcome improvement did not differ between the ACT and MBSR conditions. Both ACT and MBSR led to reduced symptoms and enhanced emotional competencies. Psychotherapeutic interventions such as these should be considered as a means of decreasing symptoms and increasing emotional competencies among individuals with MS.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics